Predicting Myeloma CAR-T Side Effects Before They Happen | Julia Noll, PhD

Predicting Myeloma CAR-T Side Effects Before They Happen | Julia Noll, PhD
Predicting Myeloma CAR-T Side Effects Before They Happen | Julia Noll, PhD
Finding Hidden Myeloma Using IMMunoPET Imaging Technology | Ola Landgren, MD, PhD
Finding Hidden Myeloma Using IMMunoPET Imaging Technology | Ola Landgren, MD, PhD
Bispecific Antibodies in CNS Myeloma: What Patients Should Know | Mahmoud Gaballa, MD
Bispecific Antibodies in CNS Myeloma: What Patients Should Know | Mahmoud Gaballa, MD
Real-world Data on patients being treated with teclistamab | Artur Jurczyszyn, MD
Real-world Data on patients being treated with teclistamab | Artur Jurczyszyn, MD
Living Longer With Myeloma: Real-World Clinic Results | James Berenson, MD
Living Longer With Myeloma: Real-World Clinic Results | James Berenson, MD
An Overview of the Most Recent Studies in Multiple Myeloma | Claudio Cerchione, MD, PhD
An Overview of the Most Recent Studies in Multiple Myeloma | Claudio Cerchione, MD, PhD
Daratumumab + lenalidomide vs lenalidomide as myeloma maintenance | Mitul Gandhi, MD
Daratumumab + lenalidomide vs lenalidomide as myeloma maintenance | Mitul Gandhi, MD
Updates on Ramantamig, a Myeloma Trispecific Antibody | Mark Wildgust, PhD
Updates on Ramantamig, a Myeloma Trispecific Antibody | Mark Wildgust, PhD
Why Some Newly Diagnosed Myeloma Patients Don’t Reach a Deep Response |Jonathan Kaufman, MD
Why Some Newly Diagnosed Myeloma Patients Don’t Reach a Deep Response |Jonathan Kaufman, MD